Altshuler David's Form 4 filing
Vertex Pharmaceuticals Inc (VRTX) · filed Feb 14, 2023
- Accession no.
- 0001209191-23-009174
- Filed
- Feb 14, 2023
- Trade date
- Feb 10-13, 2023
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 6 non-derivative transactions. Open-market sales total $1.43M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Altshuler DavidCIK 0001550395 | Officer (EVP, Global Research and CSO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 10, 2023 | Common Stock | FTax withholdingDisposed | −3,461 | $294.33 | −$1,018,676.13 | 65,184 | Direct | |
| Feb 13, 2023 | Common Stock | FTax withholdingDisposed | −5,990 | $298.26 | −$1,786,577.4 | 59,194 | Direct | |
| Feb 13, 2023 | Common Stock | SSaleDisposed | −245 | $296.44F2,F3 | −$72,627.8 | 58,949 | Direct | |
| Feb 13, 2023 | Common Stock | SSaleDisposed | −2,160 | $298.47F2,F4 | −$644,695.2 | 56,789 | Direct | |
| Feb 13, 2023 | Common Stock | SSaleDisposed | −1,893 | $299.36F2,F5 | −$566,688.48 | 54,896 | Direct | |
| Feb 13, 2023 | Common Stock | SSaleDisposed | −500 | $300.23F2,F6 | −$150,115 | 54,396 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Dr. Altshuler undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Referenced by the price of 4 transactions in Table I.
- F3
Open market sales reported on this line occurred at a weighted average price of $296.44 (range $295.84 to $296.57).
Referenced by the price of 1 transaction in Table I.
- F4
Open market sales reported on this line occurred at a weighted average price of $298.47 (range $297.85 to $298.82).
Referenced by the price of 1 transaction in Table I.
- F5
Open market sales reported on this line occurred at a weighted average price of $299.36 (range $298.86 to $299.83).
Referenced by the price of 1 transaction in Table I.
- F6
Open market sales reported on this line occurred at a weighted average price of $300.23 (range $299.96 to $300.63).
Referenced by the price of 1 transaction in Table I.